Lung cancers diagnosed at annual CT screening: Volume doubling times

Radiology

Volumn 263, Issue 2, 2012, Pages 578-583

  Henschke, Claudia I ^a,b   Yankelevitz, David F ^a   Yip, Rowena ^a   Reeves, Anthony P ^c   Farooqi, Ali ^a   Xu, Dongming ^a   Smith, James P ^d   Libby, Daniel M ^d   Pasmantier, Mark W ^d   Miettinen, Olli S ^d,e  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Arizona State University   (United States)

^c Cornell University   (United States)

^d WEILL CORNELL MEDICAL CENTER   (United States)

^e MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER CLASSIFICATION; CANCER GROWTH; CANCER SCREENING; CELL TYPE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; HUMAN; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG NODULE; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; PRIMARY TUMOR; PRIORITY JOURNAL; SCREENING TEST; TUMOR VOLUME;

CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MASS SCREENING; RADIOGRAPHIC IMAGE INTERPRETATION, COMPUTER-ASSISTED; REPRODUCIBILITY OF RESULTS; TOMOGRAPHY, X-RAY COMPUTED; TUMOR BURDEN;

EID: 84862507707     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.12102489     Document Type: Article

References (23)

1. Black WC. Computed tomography screening for lung cancer: review of screening principles and update on current status. Cancer 2007;110(11):2370- 2384.
2. Bach PB. Overdiagnosis in lung cancer: different perspectives, definitions, implications. Thorax 2008;63(4):298-300.
3. Bach PB, Silvestri GA, Hanger M, Jett JR; American College of Chest Physicians. Screening for lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007;132(3 Suppl):69S-77S.
4. Day NE, Walter SD, Collette B. Statistical models of disease natural history: their use in the evaluation of screening programmes. In: Prorok PC, Miller AB, eds. Screening for cancer. I. General on evaluation of screening for cancer and screening for lung, bladder, and oral cancer. UICC Technical Report Series No 78. Geneva, Switzerland: Union for International Cancer Control, 1984; 55-70.
5. Morrison A. Screening in chronic disease. New York, NY: Oxford University Press, 1992.
6. Duffy SW, Tabar L, Fagerberg G, et al. Breast screening, prognostic factors and survival: results from the Swedish two county study. Br J Cancer 1991;64(6):1133-1138.
7. Carter D, Vazquez M, Flieder DB, et al. Comparison of pathologic findings of baseline and annual repeat cancers diagnosed on CT screening. Lung Cancer 2007;56(2):193-199.
8. International Early Lung Cancer Action Program: enrollment and screening protocol. http://www.ielcap.org/professionals/docs/ielcap.pdf. Published July 1, 2011. Accessed February 21, 2012.
9. Henschke CI, Yankelevitz DF, Mirtcheva R, et al. CT screening for lung cancer: frequency and significance of part-solid and non-solid nodules. AJR Am J Roentgenol 2002;178(5):1053-1057.
10. Schwartz M. A biomathematical approach to clinical tumor growth. Cancer 1961;14:1272-1294.
11. Yankelevitz DF, Reeves AP, Kostis WJ, Zhao B, Henschke CI. Small pulmonary nodules: volumetrically determined growth rates based on CT evaluation. Radiology 2000;217(1):251-256.
12. Kostis WJ, Reeves AP, Yankelevitz DF, Henschke CI. Three-dimensional segmentation and growth-rate estimation of small pulmonary nodules in helical CT images. IEEE Trans Med Imaging 2003;22(10): 1259-1274.
13. Kostis WJ, Yankelevitz DF, Reeves AP, Fluture SC, Henschke CI. Small pulmonary nodules: reproducibility of three-dimensional volumetric measurement and estimation of time to follow-up CT. Radiology 2004;231(2):446-452.
14. Reeves AP, Chan AB, Yankelevitz DF, Henschke CI, Kressler B, Kostis WJ. On measuring the change in size of pulmonary nodules. IEEE Trans Med Imaging 2006;25(4):435-450.
15. Hasegawa M, Sone S, Takashima S, et al. Growth rate of small lung cancers detected on mass CT screening. Br J Radiol 2000;73(876):1252-1259.
16. Vazquez M, Flieder D, Travis W, et al. Early lung cancer action project pathology protocol. Lung Cancer 2003;39(2):231-232.
17. Vazquez M, Flieder D, Travis W, et al. International Early Lung Cancer Action Program: pathology protocol. http://www.ielcap.org/professionals/docs/ pathology-protocol.pdf. Published March 1, 2011. Accessed February 21, 2012.
18. Sobin LH, Wittekind C. TNM classification of malignant tumours. 6th ed. New York, NY: Wiley-Liss, 2002.
19. Tan BB, Flaherty KR, Kazerooni EA, Iannettoni MD; American College of Chest Physicians. The solitary pulmonary nodule. Chest 2003;123(1 Suppl):89S-96S.
20. Detterbeck FC, Gibson CJ. Turning gray: the natural history of lung cancer over time. J Thorac Oncol 2008;3(7):781-792.
21. Gould MK, Fletcher J, Iannettoni MD, et al; American College of Chest Physicians. Evaluation of patients with pulmonary nodules: when is it lung cancer? ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007;132(3 Suppl):108S-130S.
22. Ginsberg MS, Grewal RK, Heelan RT. Lung cancer. Radiol Clin North Am 2007;45(1):21-43.
23. Bach PB. Is our natural-history model of lung cancer wrong? Lancet Oncol 2008;9(7):693-697.